Creative Biogene, the world’s leading biotechnology products and services provider, focuses on offering high quality products and services, as well as proprietary technology to support the research in biomedical development and preclinical drug discovery. Recently, Creative Biogene announced the release of its complete degenerative nerve diseases diagnostic service and products for the treatment of neurodegenerative diseases.
Neurodegenerative diseases are caused by the gradual loss of neuronal structure or function in different areas of the nervous system. Many neurodegenerative diseases-including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease-are the result of neurodegenerative processes, and this disease is currently incurable. Many neurodegenerative diseases are caused by genetic mutations, most of which are in completely unrelated genes. The definite diagnosis of genetic testing is the basis for effective treatment and management of many brain and nervous system diseases. Creative Biogene has been committed to the development of many innovative products in molecular diagnostics for many years.
Among these diseases, Alzheimer's disease (AD) is the most common type of dementia. As the disease progresses, it will gradually affect the part of the brain responsible for memory, thinking, and language. Then there are symptoms such as changes in reasoning ability, aphasia, apraxia, insufficient visual and spatial ability, and changes in mood and personality. Parkinson's disease is caused by the gradual death of certain nerve cells (neurons) in the part of the brain that control movement, leading to damage and/or death. This leads to a decrease in dopamine synthesis, which leads to abnormal brain activity involved in motor control.
Creative Biogene provides a variety of diagnostic-related services, such as genetic mutation detection for neurodegenerative diseases. Creative Biogene has developed a variety of different real-time PCR and conventional
PCR diagnostic kits for research use, including PCR diagnostic kits for human diseases, animal diseases and zoonotic diseases. These kits are based on PCR technology and provide fast, sensitive and accurate detection. These PCR diagnostic kits are highly consistent with traditional methods.
“The high sensitivity and accuracy of the diagnostic kits we provide can help researchers save time, replace traditional culture tests with rapid PCR tests, and minimize the risk of false positives and false positives,” said Marcia Brady, the marketing director of Creative Biogene, “and the available kits can be applied in the field of contamination detection, laboratory diagnosis and species identification. Even, we can customize solutions to satisfy your special needs and goals.”
About Creative Biogene
Creative Biogene, as a top-of-its-kind company who holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.